Escientia Life Sciences Email Format
Pharmaceutical ManufacturingNew York, United States51-200 Employees
Escientia Life Sciences is a mid-sized pharmaceutical manufacturing company based in New York, NY. Its work centers on advancing manufacturing processes, with a focus on continuous processing and green chemistry to improve reliability in pharmaceutical production. The company targets pharmaceutical developers and manufacturers seeking more efficient, sustainable, and dependable production capabilities. This places Escientia within the pharmaceutical manufacturing sector as a provider of process-focused innovations rather than a traditional drug development entity. The company has pursued international collaborations, including a manufacturing facility in Visakhapatnam, India, and related R&D laboratories in Hyderabad, developed in partnership with Flextronics. In 2022, Escientia Switzerland AG was acquired by Deccanchemicals and renamed Primopus AG, reflecting a notable change in its corporate structure. These arrangements illustrate a history of cross-border partnerships that support its manufacturing and development initiatives.